Eli Lilly is about to report earnings. Here’s what to expect

October 29, 2026

5

Eli Lilly is slated to report third-quarter earnings and revenue, which will likely be fueled by its obesity drug Zepbound and diabetes counterpart Mounjaro.Eli Lilly is slated to report third-quarter earnings and revenue, which will likely be fueled by its obesity drug Zepbound and diabetes counterpart Mounjaro.

Eli Lilly is about to report earnings. Here’s what to expect

Related Articles

Our next steps for Alphabet stock after earnings disappoint at nearly every turn

U.S. worker job engagement hits lowest level since 2011, new Gallup poll finds

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

Latest Articles

Our next steps for Alphabet stock after earnings disappoint at nearly every turn

U.S. worker job engagement hits lowest level since 2011, new Gallup poll finds

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

Restaurant Brands reports mixed results as Burger King’s U.S. turnaround shows signs of success

Alphabet earnings miss reflects first real sign that AI is taking a bite out of search